Conflicting data exist with respect to cervical cancer, HNSCC, colorectal, gastric, and pancreatic cancer; however, over half of the published studies have found K17 to hold negative prognostic value in these cancer types. This evidence concerns the gene KRT17 and pancreatic neoplasm.